Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-22

Clinical Trial Update: Recurrent Predictive Power of Circulating Tumor Cells for Non Small Cell Lung Cancer Patients

View source ↗

Summary

This clinical trial update examines whether circulating tumor cells can predict recurrence in patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Lung Cancer Recurrent | Status: UNKNOWN